I am not going to pretend to be a great trader. Sometimes I do very well and other times, not so much. Then are times
We noted in NFTRH 337 that the EM’s were attempting to break through resistance. While this is just short-term stuff (longer-term charts remain neutral at
A subscriber asked if I was still in the SPY short or had I stopped out? Answer: Still on the short. It had been noted
Here is the Bank index, still holding support. While it looks like it could be making an extended top, the BKX is still above the
A simple update of USD. Daily USD has been gently ambling down from its high over 100. 94 (+/-) has been a likely target. Uncle
First an admin note: The reason we are not having many NFTRH+ updates lately is the same reason I kept NFTRH+ a free add-on to
First, the big picture monthly view of the €uro. How long ago it was that we charted the high risk level of 140 (+/-), at
#337 slims down to 22 pages from last week’s bulbous 42. That is because I write what the markets tell me to write and this
Well folks, the Employment report is now playing ball (to our preferred plan of economic contraction and a ‘Peak Fed’ style topping out of mainstream
Here is the S&P 500’s closing price, target price and analyst ratings from FactSet… Nothing new or unusual here. A bunch of constructive to bullish
Because we learn from the past, from mistakes and successes alike, I gained something from the old 2008 post about the miners and stock market.
Yesterday we showed the ETF charts that were at bounce points (if they were going to bounce). Today GDX and GDXJ are up around 4%.
The long, slow deceleration in US manufacturing growth continues apace. I have highlighted some of the notables, including a pop in ‘Prices’, despite the downward
Biotech, an important momentum leader to the stock market, is going to need to think about finding support soon lest this become something more than